Last edition
News about Regulation
Novartis Announces Expiration of HSR Waiting Period of Regulus Therapeutics Tender Offer
Novartis announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the HSR Act), in connection with Novartis’ previously announced tender offer to acquire all of the outstanding shares of common stock.
Regulation | 24/06/2025 | By Darshana | 194
DGTR Schedules Oral Hearing in Anti-Dumping Probe on Chianese MIPA Imports
The investigation, initiated on December 30, 2024, aims to determine whether Chinese MIPA imports are being unfairly priced and whether they are causing material injury to the Indian industry. MIPA is a key chemical used in the production of active pharmaceutical ingredients (APIs) and drug formulations.
Regulation | 24/06/2025 | By Darshana | 170
Govt Opens Export Quota for Pharma Grade Sugar with Strict Quality and Compliance Norms
Only eligible pharmaceutical exporters can apply for this quota between June 20 and July 20, 2025, exclusively through the DGFT’s online portal under “Non-SCOMET Restricted Items.” No physical applications will be accepted, and each IEC (Importer Exporter Code) holder is allowed to submit just one application, ensuring fair and transparent allocation.
Regulation | 19/06/2025 | By Darshana | 264
DoP extends timeline to apply for 11 bulk drugs under PLI scheme
The DoP invited applications from eligible manufacturers under the scheme on May 14, for products which have not been applied for or are partially produced under the scheme, by the industry.<br />
Regulation | 18/06/2025 | By Darshana | 462
MEDITECH STACKATHON 2024 Launched to Propel India's MedTech Sector Towards Innovation
Dr. Chawla emphasized the immense potential of India's MedTech industry, projecting a growth rate of 28 percent annually, with estimates indicating a market size of USD 50 billion by 2030.
Regulation | 08/05/2024 | By Abha | 1082
Government Unveils Upgraded Pharmaceuticals Scheme to Boost Industry Standards
The revised scheme, a significant step in the government's efforts, follows a comprehensive review by the Scheme Steering Committee.
Regulation | 12/03/2024 | By Abha | 970
With an investment of more than Rs 600 Crores, the project includes the construction of the medical college, hospital, and related buildings, dedicated to enhancing healthcare services for tribal communities and the wider population of Nandurbar and is expected to be completed by February 2026.
Regulation | 27/02/2024 | By Manvi | 1129
Union Minister Launches Nationwide MDA Campaign to Combat Lymphatic Filariasis
The campaign, covering 92 districts across 11 states, will span the next two weeks.
Regulation | 10/02/2024 | By Manvi | 970
India's Ministry of Health Revises Pharmaceutical Manufacturing Rules
The move is seen as a step towards aligning with international quality standards and ensuring the production of safe and high-quality drugs.
Regulation | 08/01/2024 | By Manvi | 1365
Union Cabinet has already approved the National Policy on Research and Development and Innovation in the Pharma-Med Tech Sector in India.
Regulation | 30/08/2023 | By Manvi | 1003
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy